Bookmark

Add to MyYahoo RSS

Arena Pharmaceuticals News

News on Arena Pharmaceuticals (Ticker: ARNA) continually updated from thousands of sources around the net.

17 hrs ago | Sys-Con Media

Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results

"Other recent notable achievements consist of advancing our internally discovered pipeline and lorcaserin life-cycle management programs, and establishing a marketing and supply agreement for BELVIQ in IMS Health estimates that approximately 110,000 prescriptions for BELVIQ were filled in the second quarter of 2014, representing growth of ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing, Sales, Israel, World News, Middle East

Thu Jul 31, 2014

Seeking Alpha

Cramer's Lightning Round - 6 Biotech Picks

Arena Pharmaceuticals : "I'm not a fan of it. People got mad at me because of that, but the stock is down."

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Wed Jul 30, 2014

Applied Clinical Trials

Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc...

The objective of these analyses was to identify whether there is an early treatment milestone that can predict greater than or equal to 5% weight loss at one year in patients treated with lorcaserin.

Comment?

Related Topix: Biotech, Medicine, Eisai, Healthcare Industry, Arena Pharmaceuticals, Heart Disease, Heart Failure

Mon Jul 28, 2014

Seeking Alpha

Arena Conference Call Sets Stage For Near Term Equity Movement

Arena Pharmaceuticals will be hosting its quarterly conference call on Friday, August 1st, 2014 at 8:00 AM Eastern time.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Fri Jul 25, 2014

Freshnews

Arena Pharmaceuticals to Host Corporate Update and Financial Results...

Arena Pharmaceuticals, Inc. today announced that it will provide a corporate update and report second quarter 2014 financial results before the NASDAQ Global Select Market opens on Friday, August 1, 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing

Mon Jul 21, 2014

San Diego Source

Arena subsidiary enters agreement with Israeli distributor for weight loss drug

Arena Pharmaceuticals Inc . announced on Monday that its wholly owned subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement with Abic Marketing Limited, a Teva Pharmaceutical Industries subsidiary, for its weight loss and management product Belviq.

Comment?

Related Topix: Israel, World News, Middle East, Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing, Teva Pharmaceutical Industries

Fri Jul 18, 2014

Seeking Alpha

Arena Stock Rises With Expected Jump In Belviq Sales

This week, we saw an anticipated pop in prescription numbers for the anti-obesity pill Belviq from Arena Pharmaceuticals .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing

Tue Jul 15, 2014

Applied Clinical Trials

Arena Pharmaceuticals Issued Patent for APD371 by United States Patent and Trademark Office

8,778,950, entitled "Cannabinoid Receptor Modulators," by the United States Patent and Trademark Office for APD371, an agonist of the cannabinoid receptor 2 .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Patent / Trademark Law, Law

Thu Jul 10, 2014

Freshnews

Arena Pharmaceuticals Reports that Eisai Completes Planned Increase...

Arena Pharmaceuticals, Inc. today reported that Eisai Inc. has completed its planned increase of more than 200 new contract sales representatives in its Metabolic Business Unit, increasing the sales force for BELVIQ by 50% to approximately 600.

Comment?

Related Topix: Biotech, Medicine, Eisai, Healthcare Industry, Arena Pharmaceuticals, Sales, Food and Drug Administration

Mon Jul 07, 2014

Seeking Alpha

Arena Prescription Sales OK - CEO Sales Are Not

Sales of Arena Pharmaceuticals prescription anti-obesity drug Belviq are in and are okay this week.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Benzinga

Arena Pharmaceutical Shares Dive On News CEO Sold 40% Of His Shares

Arena Pharmaceuticals shares plunged Monday on news that its chief executive Jack Lief sold nearly 40 percent of his holdings in the company.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Thu Jul 03, 2014

AmericanBankingNews.com

Arena Pharmaceuticals CEO Unloads $1,307,621 in Stock

Arena Pharmaceuticals CEO Jack Lief sold 223,525 shares of Arena Pharmaceuticals stock in a transaction that occurred on Tuesday, July 1st.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••